The I-neb is the third generation AAD (Adaptive Aerosol Delivery) system. It is a small, battery powered, lightweight and virtually silent drug delivery device designed to significantly reduce the inconvenience of conventional nebulizer/compressor therapy while delivering a precise, reproducible dose of drug. The aerosol is created through VMT (vibrating mesh technology), and the dosage of drug is controlled through an AAD Disc and specific metering chambers. The metering chambers can deliver a pre-set volume ranging from 0.25 to 1.4 mL with a residual of about 0.1 mL.
The vibrating mesh has a variable power range for the optimization of the aerosol output. I-neb incorporates an AAD algorithm that pulses medication delivery into 50 to 80 percent of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient through a liquid crystal display, and upon successful delivery of the treatment, the patient receives audible and tactile feedback.
For published clinical papers on the I-neb AAD device, please click here.